Solaris Pharma Corporation – Trademark Portfolio

Entity Type: 03

Solaris Pharma Corporation holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SOLARIS PHARMA. The owner is based in Somerset, NJ.

49 Napoleon Court

Somerset, NJ 08873

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Solaris Pharma Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Solaris Pharma Corporation have?

Solaris Pharma Corporation has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Solaris Pharma Corporation file in?

Solaris Pharma Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Solaris Pharma Corporation's most well-known trademarks?

Solaris Pharma Corporation's registered trademark portfolio includes well-known marks such as SOLARIS PHARMA. These are among 1 currently registered trademark in the portfolio.

What is Solaris Pharma Corporation's trademark registration success rate?

Solaris Pharma Corporation has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.